Dr. Lucas Boyd Kipp, MD

Dr. Kipp practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Kipp's NPI, 1548624661, was assigned on April 6, 2016. Dr. Kipp graduated from University of Western Ontario in 2009. Dr. Kipp holds California license A137774.

Dr. Kipp's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Kipp's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Kipp to 1 more hospital, named with a free account. Dr. Kipp's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kipp practices, 2 sites in all. Vendor and product names are available with a free account.

Clinical neurophysiology is Dr. Kipp's primary specialty in the NPI Registry, under taxonomy code 2084N0600X. Dr. Kipp is board certified in neurology specialty certification by the Royal College of Physicians and Surgeons of Canada. Dr. Kipp is licensed in California.

Dmand AI lists essential tremor and multiple sclerosis among the conditions Dr. Kipp treats.

CMS data shows 159 Medicare services from Dr. Kipp across 3 procedure codes in 2024, for 72 Medicare patients. Medicare paid $14,596 for them.

CMS counts 72 Medicare patients who saw Dr. Kipp in 2024. The largest group is under 65, with 35 patients. 54% of them have high cholesterol, and 47% have high blood pressure. 33% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kipp's median patient age at 47, with 69% women.

In 2024, Dr. Kipp wrote 344 Medicare Part D claims for 37 patients. 92% of them were for generic drugs. CMS names the drug for 306 of them, across 12 drugs with 11 or more claims each, at $78,214 in total drug cost. In 2023, CMS named 269 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Kipp for performance year 2024, reported as part of a group. Dr. Kipp accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kipp as offering telehealth.

Dmand AI links 15 papers to Dr. Kipp, published from 2014 to 2024. 2019 was the busiest year, with 3. The most frequent topics are Multiple Sclerosis, Brain and Autoimmune Diseases. Dr. Kipp has published most often in Mult Scler. Dr. Kipp's most frequent co-authors are Jeffrey Edward Dunn, MD, May H. Han, MD and William Hewitt Robinson, MD.

CMS Open Payments shows 48 general payments to Dr. Kipp from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Novartis Pharmaceuticals Corporation paid the most, $721.

Dr. Kipp graduated from University of Western Ontario in 2009.

Dr. Kipp is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.